Durant J, Chantre PH, Gonzalez G, et al. Efficacy and safety of
Buxussempervirens
L. preparations (SPV-30) in HIV-infected asymptomatic patients: a multicentre, randomized, double-blind, placebo-controlled trial.
Phytomedicine.
1998;5:1 - 10.
Durant J, Chantre PH, Gonzalez G, et al. Efficacy and safety of
Buxussempervirens
L. preparations (SPV-30) in HIV-infected asymptomatic patients: a multicentre, randomized, double-blind, placebo-controlled trial.
Fitomedicina.
1998;5:1 - 10.
Durant J, Chantre PH, Gonzalez G, et al. Efficacy and safety of
Buxussempervirens
L. preparations (SPV-30) in HIV-infected asymptomatic patients: a multicentre, randomized, double-blind, placebo-controlled trial.
Phytomedicine.
1998;5:1 - 10.
PDR for Herbal Medicines.
Montvale, NJ: Medical Economics Company; 2000:116.
PDR for Herbal Medicines.
Montvale, NJ: Medical Economics Company; 1998:703.
Gulick RM, McAuliffe V, Holden-Wiltse J, et al. Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258.
Ann Intern Med
. 1999;130:510 - 514.
Craig GB, Darnell BE, Weinsier RL, et al. Decreased fat and nitrogen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formula vs those receiving long-chain-triglyceride-containing formula.
J Am DietAssoc.
1997;97:605 - 611.
Wanke CA, Pleskow D, Degirolami PC, et al. A medium chain triglyceride-based diet in patients with HIV and chronic diarrhea reduces diarrhea and malabsorption: a prospective, controlled trial.
Nutrition
. 1996;12:766 - 771.
Shabert JK, Winslow C, Lacey JM, et al. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial.
Nutrition
. 1999;15:860 - 864.
Clark RH, Feleke G, Din M, et al. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study.
JPEN J Parenter Enteral Nutr
. 2000;24:133 - 139.
Bounous G, Baruchel S, Falutz J, et al. Whey proteins as a food supplement in HIV-seropositive individuals.
Clin Invest Med.
1993;16:204 - 209.
Scevola D, Oberto L, Faggi A, et al. Fish oil in the treatment of wasting syndrome [abstract].
Int Conf AIDS
. 1996;11:122.
Kinscherf R, Fischbach T, Mihm S, et al.Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells.
FASEB J
. 1994;8:448 - 451.
Akerlund B, Jarstrand C, Lindeke B, Sonnerborg A, Akerblad C, Rasool O. Effect of N-acetylcystine (NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial.
Eur J Clin Pharmacol
. 1996;50:457 - 461.
Look MP, Rockstroh JK, Rao GS, et al. Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study
. Eur J Clin Invest
. 1998;28:389 - 397.
Walker RE, Lane HC, Boenning CM, et al. The safety, pharmacokinetics, and antiviral activity of N-acetylcysteine in HIV-infected individuals [abstract].
J CellBiochem Suppl.
1992;16:89.
Pichard C, Sudre P, Karsegard V, et al. A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study.
AIDS.
1998;12:53 - 63.
Plettenberg A, Stoehr A, Stellbrink HJ, et al. A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea.
Clin Investig
. 1993;71:42 - 45.
Greenberg PD, Cello JP. Treatment of severe diarrhea caused by
Cryptosporidium parvum
with oral bovine immunoglobulin concentrate in patients with AIDS.
J Acquir Immune Defic Syndr Hum Retrovirol
. 1996;13:348 - 354.
Okhuysen PC, Chappell CL, Crabb J, et al. Prophylactic effect of bovine anti-
Cryptosporidium
hyperimmune colostrum immunoglobulin in healthy volunteers challenged with
Cryptosporidium parvum
.
Clin Infect Dis.
1998;26:1324 - 1329.
Vazquez JA, Vaishampayan J, Arganoza MT, et al. Use of an over-the-counter product, Breathaway (Melaleuca Oral Solution), as an alternative agent for refractory oropharyngeal candidiasis in AIDS patients [abstract].
Int Conf AIDS
. 1996;11:109.
Quale JM, Landman D, Zaman MM, et al. In vitro activity of
Cinnamomumzeylanicum
against azole resistant and sensitive
Candida
species and a pilot study of cinnamon for oral candidiasis.
Am J Chin Med
. 1996;24:103 - 109.
Christeff N, Melchior JC, Mammes O, et al. Correlation between increased cortisol: DHEA ratio and malnutrition in HIV-positive men.
Nutrition.
1999;15:534 - 539.
Cruess DG, Antoni MH, Kumar M, et al. Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men.
Psychoneuroendocrinology
. 1999;24:537 - 549.
Rabkin JG, Ferrando SJ, Wagner GJ, et al. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters.
Psychoneuroendocrinology.
2000;25:53 - 68.
Burack JH, Cohen MR, Hahn JA, et al. Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms.
J Acquir ImmuneDefic Syndr Hum Retrovirol
. 1996;12:386 - 393.
Weber R, Christen L, Loy M, et al. Randomized, placebo-controlled trial of Chinese herb therapy for HIV-1-infected individuals.
J Acquir Immune Defic Syndr HumRetrovirol
. 1999;22:56 - 64.
Baum MK, Javier JJ, Mantero-Atienza E, et al. Zidovudine-associated adverse reactions in a longitudinal study of asymptomatic HIV-1-infected homosexual males.
J Acquir Immune Defic Syndr
. 1991;4:1218 - 1226.
Mocchegiani E, Rivabene R, Santini MT. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS.
Int JImmunopharmacol.
1995;17:719 - 727.
Semino-Mora MC, Leon-Monzon ME, Dalakas MC. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes.Part I: L-carnitine prevents the myotoxicity of AZT in vitro.
Lab Invest
. 1994;71:102 - 112.
Dalakas MC, Leon-Monzon ME, Bernardini I, et al. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.
Ann Neurol
. 1994;35:482 - 487.
Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
N Engl J Med.
1987;317:192 - 197.
Akerlund B, Tynell E, Bratt G, et al. N-acetylcysteine treatment and the risk of toxic reactions to trimethoprim-sulphamethoxazole in primary
Pneumocystiscarinii
prophylaxis in HIV-infected patients.
J Infect.
1997;35:143 - 147.
Walmsley SL, Khorasheh S, Singer J, et al. A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in
Pneumocystis carinii
pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group.
J Acquir Immune Defic Syndr Hum Retrovirol
. 1998;19:498 - 505.
Sappey C, Leclercq P, Coudray C, et al. Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency.
Clin Chim Acta
. 1994;230:35 - 42.
Tomaka FL, Imoch PJ, Reiter WM, et al. Prevalence of nutritional deficiencies in patients with HIV Infection [abstract].
Int Conf AIDS.
1994;10:221.
Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression.
AIDS
. 1995;9:1051 - 1056.
Schuhmacher M, Peraire J, Domingo JL, et al. Trace elements in patients with HIV-1 infection.
Trace Elem Electrolytes
. 1994;11:130 - 134.
Periquet BA, Jammes NM, Lambert WE, et al. Micronutrient levels in HIV-1-infected children.
AIDS.
1995;9:887 - 893.
Boudes P, Zittoun J, Sobel A. Folate, vitamin B12, and HIV infection [letter].
Lancet
. 1990;335:1401 - 1402.
Butterworth RF, Gaudreau C, Vincelette J, et al. Thiamine deficiency in AIDS [letter].
Lancet
. 1991;338:1086.
Baum MK, Javier JJ, Mantero-Atienza E, et al. Zidovudine-associated adverse reactions in a longitudinal study of asymptomatic HIV-1-infected homosexual males.
J Acquir Immune Defic Syndr
. 1991;4:1218 - 1226.
Rule SA, Hooker M, Costello C, et al. Serum vitamin B12 and transcobalamin levels in early HIV disease.
Am J Hematol
. 1994;47:167 - 171.
Cirelli A, Ciardi M, de Simone C, et al. Serum selenium concentration and disease progress in patients with HIV infection.
Clin Biochem
. 1991;24:211 - 214.
Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS).
ChemBiol Interact.
1994;91:181 - 186.
Constans J, Pellegrin JL, Sergeant C, et al. Serum selenium predicts outcome in HIV infection. [letter].
J Acquir Immune Defic Syndr HumRetrovirol
. 1995;10:392.
Look MP, Rockstroh JK, Rao GS, et al. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection.
EurJ Clin Nutr
. 1997;51:266 - 272.
Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency.
J Acquir Immune DeficSyndrHum Retrovirol.
1997;15:370 - 374.
Campa A, Shor-Posner G, Indacochea F, et al. Mortality risk in selenium-deficient HIV-positive children.
J Acquir Immune Defic Syndr Hum Retrovirol
. 1999;20:508 - 513.
Semba RD, Graham NM, Caiaffa WT, et al. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection.
Arch InternMed.
1993;153:2149 - 2154.
Bianchi-Santamaria A, Fedeli S, Santamaria L. Short communication: possible activity of beta-carotene in patients with the AIDS related complex. A pilot study.
Med Oncol Tumor Pharmacother.
1992;9:151 - 153.
Alexander M, Newmark H, Miller RG. Oral beta-carotene can increase the number of OKT4+ cells in human blood.
Immunol Lett
. 1985;9:221 - 224.
Fryburg DA, Mark RJ, Griffith BP, et al. The effect of supplemental beta-carotene in immunologic indices in patients with AIDS: a pilot study.
Yale J Biol Med
. 1995;68:19 - 23.
Coodley GO, Nelson HD, Loveless MO, et al. Beta-carotene in HIV infection.
J Acquir Immune Defic Syndr Hum Retrovirol.
1993;6:272 - 276.
Coodley GO, Nelson HD, Loveless MO, et al. Beta-carotene in HIV infection.
J Acquir Immune Defic Syndr Hum Retrovirol.
1993;6:272 - 276.
Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV infection: an extended evaluation.
AIDS
. 1996;10:967 - 973.
Constans J, Delmas-Beauvieux MC, Sergeant C, et al. One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study [letters].
Clin Infect Dis
. 1996;23:654 - 656.
Tang AM, Graham NHM, Kirby AJ, et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men.
Am JEpidemiol.
1993;138:937 - 951.
Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection.
Am JEpidemiol.
1996;143:1244 - 1256.
Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania.
JAcquir Immune Defic Syndr Hum Retrovirol.
2000;23:246-254.
Coutsoudis A, Pillay K, Spooner E, et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group.
AIDS.
1999;13:1517 - 1524.
Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection.
Am JEpidemiol.
1996;143:1244 - 1256.
Tang AM, Graham NHM, Kirby AJ, et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men.
Am JEpidemiol.
1993;138:937 - 951.
Shor-Posner G, Morgan R, Wilkie F, et al. Plasma cobalamin levels affect information processing speed in a longitudinal study of HIV-1 disease.
Arch Neurol
. 1995;52:195 - 198.
Kieburtz KD, Giang DW, Schiffer RB, et al. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction.
Arch Neurol
. 1991;48:312 - 314.
Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression.
AIDS
. 1995;9:1051 - 1056.
Baum MK, Mantero-Atienza E, Shor-Posner G, et al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection.
J Acquir Immune Defic Syndr.
1991;4:1122 - 1132.
Harakeh S, Jariwalla RJ, Pauling L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells.
Proc Natl Acad Sci U S A.
1990;87:7245 - 7249.
Cathcart RF III. Vitamin C in the treatment of acquired immune deficiency syndrome (AIDS).
Med Hypotheses.
1984;14:423 - 433.
Tang AM, Graham NHM, Kirby AJ, et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men.
Am JEpidemiol.
1993;138:937 - 951.
Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men.
J Acquir Immune Defic Syndr
. 1993;6:949 - 958.
Allard JP, Aghdassi E, Chau J, et al. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects.
AIDS
. 1998;12:1653 - 1659.
Gogu SR, Beckman BS, Rangan SR, et al. Increased therapeutic efficacy of zidovudine in combination with vitamin E.
Biochem Biophys ResCommun
. 1989;165:401 - 407.
Bogden JD, Kemp FW, Han S, et al. Status of selected nutrients and progression of human immunodeficiency virus type 1 infection.
Am J Clin Nutr.
2000;72:809 - 815.
Castaldo A, Tarallo L, Palomba E, et al. Iron deficiency and intestinal malabsorption in HIV disease.
J Pediatr Gastroenterol Nutr
. 1996;22:359 - 363.
Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men.
J Acquir Immune Defic Syndr
. 1993;6:949 - 958.
Schrauzer GN, Sacher J. Selenium in the maintenance and therapy of HIV-infected patients.
Chem Biol Interact.
1994;91:199 - 205.
Constans J, Pellegrin JL, Sergeant C, et al. Serum selenium predicts outcome in HIV infection. [letter].
J Acquir Immune Defic Syndr HumRetrovirol
. 1995;10:392.
Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency.
J Acquir Immune DeficSyndrHum Retrovirol.
1997;15:370 - 374.
Campa A, Shor-Posner G, Indacochea F, et al. Mortality risk in selenium-deficient HIV-positive children.
J Acquir Immune Defic Syndr Hum Retrovirol
. 1999;20:508 - 513.
Baeten JM, Mostad SB, Hughes MP, et al. Selenium deficiency is associated with shedding of HIV-1--infected cells in the female genital tract.
J Acquir Immune Defic Syndr
. 2001;26:360 - 364.
Olmsted L, Schrauzer GN, Flores-Arce M, et al. Selenium supplementation of symptomatic human immunodeficiency virus infected patients.
Biol TraceElem Res
. 1989;20:59 - 65.
Constans J, Delmas-Beauvieux MC, Sergeant C, et al. One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study [letters].
Clin Infect Dis
. 1996;23:654 - 656.
Look MP, Rockstroh JK, Rao GS, et al. Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study
. Eur J Clin Invest
. 1998;28:389 - 397.
Zazzo JF, Chalas J, Lafont A, et al. Is nonobstructive cardiomyopathy in AIDS a selenium deficiency-related disease?[letter].
JPEN J Parenter Enteral Nutr.
1988;12:537 - 538.
Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS).
Chem Biol Interact.
1994;91:181 - 186.
Fabris N, Mocchegiani E, Galli M, et al. AIDS, zinc deficiency, and thymic hormone failure [letter].
JAMA.
1988;259:839 - 840.
Sappey C, Leclercq P, Coudray C, et al. Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency.
Clin Chim Acta
. 1994;230:35 - 42.
Odeh M. The role of zinc in acquired immunodeficiency syndrome.
JIntern Med
. 1992;231:463 - 469.
Periquet BA, Jammes NM, Lambert WE, et al. Micronutrient levels in HIV-1-infected children.
AIDS.
1995;9:887 - 893.
Tomaka FL, Imoch PJ, Reiter WM, et al. Prevalence of nutritional deficiencies in patients with HIV Infection [abstract].
Int Conf AIDS.
1994;10:221.
Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression.
AIDS
. 1995;9:1051 - 1056.
Campa A, Lai H, Shor-Posner G, et al. Relationship between zinc deficiency and survival in HIV+ homosexual men [abstract].
FASEB J
. 1998;12:A217.
Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression.
AIDS
. 1995;9:1051 - 1056.
Bogden JD, Kemp FW, Han S, et al. Status of selected nutrients and progression of human immunodeficiency virus type 1 infection.
Am J Clin Nutr.
2000;72:809 - 815.
Mocchegiani E, Rivabene R, Santini MT. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS.
Int JImmunopharmacol.
1995;17:719 - 727.
Tang AM, Graham NHM, Kirby AJ, et al. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men.
Am JEpidemiol.
1993;138:937 - 951.
Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection.
Am JEpidemiol.
1996;143:1244 - 1256.
Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men.
J Acquir Immune Defic Syndr
. 1993;6:949 - 958.
Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection.
Am JEpidemiol.
1996;143:1244 - 1256.
Piscitelli SC, Burstein AH, Chaitt D, et al. Indinavir concentrations and St. John's wort.
Lancet.
2000;355:547 - 548.
Piscitelli SC. Use of complementary medicines by patients with HIV: Full sail into uncharted waters. Medscape HIV/AIDS. 2000;6.
Piscitelli SC, Burstein AH, Welden N, et al. The effect of garlic supplements on the pharmacokinetics of saquinavir.
Clin Infect Dis
. 2002;34:234 - 238.
Piketty C, Jayle D, Leplege A, et al. Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease.
Clin Endocrinol (Oxf).
2001;55:325 - 330.
Agin D, Gallagher D, Wang J, et al. Effects of whey protein and resistance exercise on body cell mass, muscle strength, and quality of life in women with HIV.
AIDS
. 2001;15:2431 - 2440.
de Maat MM, Hoetelmans RM, Mathot RA, et al. Drug interaction between St. John's wort and nevirapine [letter].
AIDS
. 2001;15:420 - 421.
Hart LA, Nibbering PH, van den Barselaar MT, et al. Effects of low molecular weight constituents from Aloe vera gel on oxidative metabolism and cytotoxic and bactericidal activities of human neutrophils.
Int J Immunopharmacol
. 1990;12:427 - 434.
Sheets MA, Unger BA, Giggleman GF, et al. Studies of the effect of acemannan on retrovirus infections: clinical stabilization of feline leukemia virus-infected cats.
Mol Biother
. 1991;3:41 - 45.
Kemp MC, Kahlon JB, Chinnah AD, et al. In-vitro evaluation of the antiviral effects of acemannan on the replication and pathogenesis of HIV-1 and other enveloped viruses: Modification of the processing of glycoprotein precursors [abstract].
Antiviral Res
. 1990;13(Suppl 1):83.
Pugh N, Ross SA, ElSohly MA, et al. Characterization of Aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity.
J Agric Food Chem
. 2001;49:1030 - 1034.
Montaner JS, Gill J, Singer J, et al. Double-blind placebo-controlled pilot trial of acemannan in advanced human immunodeficiency virus disease.
J Acquir Immune Defic Syndr Hum Retrovirol
. 1996;12:153 - 157.
Birk TJ, McGrady A, MacArthur RD, et al. The effects of massage therapy alone and in combination with other complementary therapies on immune system measures and quality of life in human immunodeficiency virus.
J Altern Complement Med
. 2000;6:405 - 414.
Diego MA, Field T, Hernandez-Reif M, et al. HIV adolescents show improved immune function following massage therapy.
Int J Neurosci
. 2001;106:35 - 45.
Ironson G, Field T, Scafidi F, et al. Massage therapy is associated with enhancement of the immune system's cytotoxic capacity.
Int J Neurosci
. 1996;84:205 - 217.
Último revisado Octubre 2003 por EBSCO CAM Medical Review Board
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
Copyright © EBSCO Publishing. All rights reserved.